Enanta Pharmaceuticals Inc (ENTA) stock news · rev $65.3M
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
This ENTA news page leads with what Enanta Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ENTA yet. We will not pad this page with generic market recap.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ENTA stock page; for the tape open the quote page.
ENTA stock news FAQ
What are ENTA's latest revenue and net income?
Latest cached Enanta Pharmaceuticals Inc (ENTA) revenue for Sep 30, 2025 was $65.3M. Net income was -$81.9M. Statements: https://lician.com/financials/enta
How did ENTA revenue change from the prior cached period?
Cached Enanta Pharmaceuticals Inc (ENTA) revenue was down 3.4% from $67.6M (Sep 30, 2024) to $65.3M (Sep 30, 2025). Statements: https://lician.com/financials/enta
What is ENTA's market cap?
Enanta Pharmaceuticals Inc (ENTA) market cap is $328.0M on the latest cached fundamentals snapshot.
What kind of company is ENTA?
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Where is ENTA stock news listed?
Cached stock news for Enanta Pharmaceuticals Inc (ENTA) is listed at https://lician.com/news/enta. Filings: https://lician.com/sec/enta
Not investment advice.